Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
OPERATING ACTIVITIES:
Net loss	$ (53,698)	$ (42,190)
Adjustments to reconcile net loss to net cash provided by operating activities:
Share-based compensation expense	7,165	9,538
Depreciation and amortization expense, including amortization of deferred financing costs	49,451	58,462
Deferred rent	(837)	(7,051)
(Income) loss from unconsolidated real estate ventures, net	592	(975)
Amortization of market lease intangibles, net	(69)	58
Amortization of lease incentives	3,865	2,696
Loss on the extinguishment of debt	4,636
Impairment loss	8,483	17,211
Gain on the sale of real estate, net	(537)	(197)
Loss on operating lease and other receivables	706	311
(Income) loss from investments, net	438	(20)
Return on capital from unconsolidated real estate ventures	390	1,179
Other non-cash items	1,308	365
Changes in operating assets and liabilities:
Tenant and other receivables	1,674	3,710
Other assets, net	(1,830)	464
Accounts payable and accrued expenses	(7,482)	(6,015)
Other liabilities, net	(1,320)	(503)
Net cash provided by operating activities	12,935	37,043
INVESTING ACTIVITIES:
Development costs, construction in progress and real estate additions	(29,091)	(47,982)
Proceeds from the sale of real estate	188,779	12,410
Proceeds from derivative financial instruments	2,537	1,465
Distributions of capital from unconsolidated real estate ventures and other investments	465	160,250
Investments in unconsolidated real estate ventures and other investments	(1,376)	(2,541)
Net cash provided by investing activities	161,314	123,602
FINANCING ACTIVITIES:
Borrowings under mortgage loans	265,205	31,600
Borrowings under revolving credit facility	197,000	30,000
Repayments of mortgage loans	(408,040)	(786)
Repayments of revolving credit facility	(120,000)	(92,000)
Payments on derivative financial instruments	(1,104)	(1,465)
Debt issuance and modification costs	(5,207)	(10)
Proceeds from common shares issued pursuant to ESPP	244	292
Common shares repurchased	(147,593)	(49,444)
Dividends paid to common shareholders	(14,788)	(16,066)
Distributions to redeemable noncontrolling interests	(2,823)	(2,931)
Distributions to noncontrolling interests		(10)
Net cash used in financing activities	(237,106)	(100,820)
Net increase (decrease) in cash and cash equivalents, and restricted cash	(62,857)	59,825
Cash and cash equivalents, and restricted cash, beginning of period	183,192	200,441
Cash and cash equivalents, and restricted cash, end of period	120,335	260,266
SUPPLEMENTAL DISCLOSURE OF CASH FLOW AND NON-CASH INFORMATION:
Cash paid for interest (net of capitalized interest of $998 and $3,008 in 2025 and 2024)	32,653	25,623
Accrued capital expenditures included in accounts payable and accrued expenses	40,768	77,358
Write-off of fully depreciated assets	11,954	10,574
Accrual for common shares repurchased pending settlement	40,142
Redemption of OP Units for common shares	9,719	7,875
Cash paid for amounts included in the measurement of lease liabilities for operating leases	$ 1,664	$ 1,616